In order to standardize the review and comment of national key monitoring drug prescriptions （medical orders） by medical institutions at all levels， the Sichuan Academy of Medical Sciences·Sichuan Provincial People’s Hospital took the lead in compiling the

Review and Comment Rules of National Key Monitoring Drugs prescriptions

（

Medical Orders

）

herein after referred to as the

Rules

in accordance with the

Second Batch of National Key Monitoring Rational Drug Use List

（hereinafter referred to as the

List

） issued by the National Health Commission confirmed in Jan. 13， 2023. According to the laws and drug instructions issued by the national drug regulatory department， clinical guidelines and expert consensus， combined with the actual situation of patients （including age， body weight， liver and kidney function）， the writing group classified the common and unreasonable drug use problems for 30 kinds of drugs included in the

List

and develop the review and comment details. After two rounds of Delphi method questionnaire research and experts’ online meetings， and reviewed by the steering committee， the final

Rules

was formed. The

Rules

aim to provide reference for the evaluation of the rational use of drugs included in the

List

by medical institutions， so as to realize the standardized management of key monitoring drugs， promote the rational drug use in medical institutions， and ensure the safety of drug use for patients.